IRCT20190212042686N3
The effect of royal jelly supplementation on hormonal status,insulin resistance and inflammatory factors in patients with polycystic ovary syndrome
The effect of royal jelly supplementation on hormonal status, insulin resistance and inflammatory factors in patients with polycystic ovary syndrome: pilot study
Tabriz University of Medical Sciences·Phase 2·Iranian Registry Of Clinical Trial·biologicalRecruiting
Study focus
- Disease/Condition
- Polycystic ovarian syndrome
- Study type
- Interventional
- Intervention type
- biological
Sponsor & location
- Primary sponsor
- Tabriz University of Medical Sciences
- Location
- Iran
Timeline & enrollment
- Phase
- Phase 2
- Start date
- Dec 05, 2022
- End date
- N/A
ICD-10 classifications
Polycystic ovarian syndromeOvarian dysfunction, unspecifiedOvarian dysfunctionOther ovarian dysfunctionOther and unspecified ovarian cysts
Data source
- Registry
- Iranian Registry Of Clinical Trial
- Trial ID
- IRCT20190212042686N3
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for IRCT20190212042686N3 through Pure Global AI's free database. This Phase 2 trial is sponsored by Tabriz University of Medical Sciences and is currently Recruiting. The study focuses on Polycystic ovarian syndrome.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Iranian Registry Of Clinical Trial data, helping medical device and pharmaceutical companies navigate clinical research efficiently.